Evidence map›Paper›PMID 42002763›Full record

ArticleGenome medicine2026

DposFinder: an interpretable transformer model for predicting phage-derived polysaccharide depolymerases and their host capsular serotypes.

Yanxiang Shen, Heyuan Lun, Yumeng Zhang, Zhikang Wang, Cui Tai, Xiaohua Chen, Jiangning Song, Ping He, Hong-Yu Ou

Abstract read
In one paragraph

Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanxiang Shen *Department of Infectious Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Heyuan Lun *Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Yumeng ZhangState Key Laboratory of Microbial Metabolism, Joint International Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Zhikang WangBiomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.
Cui TaiState Key Laboratory of Microbial Metabolism, Joint International Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Xiaohua ChenDepartment of Infectious Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. chenxiaohua2000@163.com.
Jiangning SongBiomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia. Jiangning.Song@monash.edu.
Ping HeDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. hpatsh@sjtu.edu.cn.
Hong-Yu OuDepartment of Infectious Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. hyou@sjtu.edu.cn.

Funding

National Key Research and Development Program of China 2024YFE0199000National Natural Science Foundation of China 32370186Shanghai Hospital Development Center Foundation SHDC2022CRD041Talent Program on academic clinicians of Shanghai Jiao Tong University School of Medicine 20240818Talent Program on Public Health System Construction of Shanghai GWV1-11.2-XD01
6 · The paper itself

Abstract

backgroundPolysaccharide depolymerases derived from phages play a pivotal role in the degradation of bacterial surface polysaccharides, offering a promising strategy to address antibiotic-resistant bacterial strains. However, the identification of these enzymes along with their associated host capsular serotypes poses significant challenges. This study introduces DposFinder, a transformer-based deep learning framework designed to predict depolymerases alongside their host capsular serotypes, thereby facilitating large-scale discovery and application of these enzymes.

methodsWe developed DposFinder as an interpretable model based on transformer architecture, utilizing the pre-trained protein language model ESM-2. The model’s attention mechanism was harnessed to pinpoint β-helix domains of depolymerases and predict their corresponding host capsular serotypes. DposFinder’s performance was evaluated through extensive benchmarking and experimental validation involving sequenced phages of Klebsiella pneumoniae.

resultsDposFinder achieved state-of-the-art performance, with an area under the ROC curve (AUC) of 0.991 on an independent test dataset, outperforming existing depolymerase prediction tools. Experimental validation confirmed the predictions of six novel depolymerases, which exhibited less than 50% sequence identity with known depolymerases. Furthermore, DposFinder successfully predicted the host capsular serotypes for the identified depolymerases. The utility of the model was further demonstrated through improved plasmid electroporation efficiency in hypermucoviscous K. pneumoniae isolates and the facilitation of host-serotype-labeled phage library construction. A publicly accessible database was also established, containing over 100,000 putative depolymerases derived from more than 440,000 phage genomic sequences.

conclusionsDposFinder is a novel framework capable of predicting both depolymerases and their associated host capsular serotypes. Its interpretative capabilities and scalability render it a powerful tool for expediting the discovery and application of phage-derived depolymerases in biomedical research and phage therapy.

Indexed as

Bacterial CapsulesBacteriophagesGlycoside HydrolasesKlebsiella pneumoniaeSerogroupGlycoside HydrolasesCapsular serotypeKlebsiella pneumoniaePhage therapyPolysaccharide depolymeraseTransformer

Identifiers

PMID42002763
PMCPMC13224497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.